Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients

Journal of Pain

Volumn 14, Issue 4, 2013, Pages 384-392

  Chen, Lucy ^a   Vo, Trang ^a   Seefeld, Lindsey ^a   Malarick, Charlene ^a   Houghton, Mary ^a   Ahmed, Shihab ^a   Zhang, Yi ^a   Cohen, Abigail ^a   Retamozo, Cynthia ^a   St Hilaire, Kristen ^a   Zhang, Vivian ^a   Mao, Jianren ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chronic pain; Numeric pain score; Opioid dose adjustment; Opioid therapy

Indexed keywords

FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE SULFATE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PERCOCET; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL EFFECTIVENESS; DOSE CALCULATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAIN ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; DOSE RESPONSE; PERSONALIZED MEDICINE;

ANALGESICS, OPIOID; CHRONIC PAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84884468631     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2012.12.012     Document Type: Article

References (29)

1. Ballantyne JC, Mao J: Opioid therapy for chronic pain. N Engl J Med 349:1943-1953, 2003
2. Ballantyne JC, Shin NS: Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain 24:469-478, 2008
3. Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP: Agedependent opioid escalation in chronic pain patients. Anesth Analg 100:1740-1745, 2005
4. Cepeda MS, Etropolski M, Weinstein R, Fife D, Boston R, Matcho A: Dose patterns in commercially insured subjects chronically exposed to opioids: A large cohort study in the United States. BMC Palliat Care 9:14, 2010
5. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM: Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base. J Pain 11: 807-829, 2010
6. Chen L, Houghton M, Seefeld L, Malarick C, Mao J: Opioid therapy for chronic pain: Physicians' attitude and current practice patterns. J Opioid Manag 7:267-276, 2011
7. Chen L, Malarick C, Seefeld L, Wang S, Houghton M, Mao J: Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 143:65-70, 2009
8. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C: American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10:113-130, 2009
9. Cifuentes M,Webster B, Genevay S, Pransky G: The course of opioid prescribing for a new episode of disabling low back pain: Opioid features and dose escalation. Pain 151: 22-29, 2010
10. Cohen SP, Wang S, Chen L, Kurihara C, McKnight G, Marcuson M, Mao J: An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain. J Pain Symptom Manage 37:698-708, 2009
11. Cortinas Saenz M, Geronimo Pardo M, Cortinas Saenz ML, Hernandez Vallecillo MT, Ibarra Marti ML, Mateo Cerdan CM: Acute opiate tolerance and postoperative hyperalgesia after a brief infusion of remifentanil managed with multimodal analgesia. Rev Esp Anestesiol Reanim 55: 40-42, 2008
12. Fitzcharles MA, Ste-Marie PA, Gamsa A, Ware MA, Shir Y: Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med 124:955-960, 2011
13. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E: Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 174:1589-1594, 2006
14. Hayek SM, Veizi IE, Narouze SN, Mekhail N: Age-dependent intrathecal opioid escalation in chronic noncancer pain patients. Pain Med 12:1179-1189, 2011
15. Jamison RN, Link CL, Marceau LD: Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med 10:1084-1094, 2009
16. Jensen MK, Thomsen AB, Hojsted J: 10-year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization. Eur J Pain 10: 423-433, 2006
17. Kalso E, Edwards JE, Moore RA, McQuay HJ: Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 112:372-380, 2004
18. Kerr C, Holahan T, Milch R: The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: A case series. J Palliat Med 14:1074-1077, 2011
19. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L: A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14:145-161, 2011
20. Maier C, Schaub C, Willweber-Strumpf A, Zenz M: Longterm efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment. Schmerz 19:410-417, 2005
21. Mercadante S, Gebbia V, David F, Aielli F, Verna L, Porzio G, Ferrera P, Casuccio A, Ficorella C: Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer 47:713-717, 2011
22. Morse JS, Stockbridge H, Egan KB, Mai J, Wickizer T, Franklin GM: Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline. J Opioid Manag 7:427-433, 2011
23. Moulin DE, Palma D,Watling C, Schulz V: Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci 32:340-343, 2005
24. Nalamachu S: Opioid rotation with extended-release opioids:Where shouldwebegin? Int JGenMed5:11-17, 2012
25. Nedeljkovic SS, Wasan A, Jamison RN: Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain 18:S39-S51, 2002
26. Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P: Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8:287-313, 2008
27. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D: Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348:1223-1232, 2003
28. Tennant FS J, Uelmen GF: Narcotic maintenance for chronic pain. Medical and legal guidelines. Postgrad Med 73:81-83, 86-88, 91-93, 1983
29. Vorobeychik Y, Gordin V, Mao J, Chen L: Combination therapy for neuropathic pain: A review of current evidence. CNS Drugs 25:1023-1034, 2011